Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1994 Sep;71(3):217-9; discussion 219-20. doi: 10.1136/adc.71.3.217

Influence of spacer device on drug delivery to young children with asthma.

L Agertoft 1, S Pedersen 1
PMCID: PMC1063523  PMID: 7979494

Abstract

The budesonide dose delivered to the patient from three different spacer devices (Nebuhaler = 750 ml, Aerochamber = 140 ml, and Babyspacer = 260 ml) was assessed by measuring the budesonide dose deposited on a filter inserted between the spacer outlet and the mouth of the patient. Twenty children aged 10-25 months were given a single dose of 200 micrograms budesonide from each spacer device in a randomised crossover study. All spacers had a facemask attached and a one way valve system. The children breathed through the inhalation system for 30 seconds. Furthermore, the minute ventilation of the children through a tightly fitting facemask was measured. The filter dose of budesonide was significantly lower after Aerochamber treatment (39.4 micrograms, range 19-67 micrograms) than after Nebuhaler (53.5 micrograms, range 34-88 micrograms) and Babyspacer (55.5 micrograms, range 39-76 micrograms) treatment. The minute ventilation of the children varied from 1.4 l/min to 7.0 l/min (mean 5.0 l/min). This was sufficient to empty all spacers within the 30 seconds of inhalation. It is concluded that spacer volume does not seem to be so important for children aged 10-25 months as long as spacers with a volume lower than 750 ml are used.

Full text

PDF
217

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crimi N., Palermo F., Cacopardo B., Vancheri C., Oliveri R., Palermo B., Mistretta A. Bronchodilator effect of Aerochamber and Inspirease in comparison with metered dose inhaler. Eur J Respir Dis. 1987 Sep;71(3):153–157. [PubMed] [Google Scholar]
  2. Everard M. L., Clark A. R., Milner A. D. Drug delivery from holding chambers with attached facemask. Arch Dis Child. 1992 May;67(5):580–585. doi: 10.1136/adc.67.5.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Lee H., Evans H. E. Evaluation of inhalation aids of metered dose inhalers in asthmatic children. Chest. 1987 Mar;91(3):366–369. doi: 10.1378/chest.91.3.366. [DOI] [PubMed] [Google Scholar]
  4. Lødrup Carlsen K. C., Nikander K., Carlsen K. H. How much nebulised budesonide reaches infants and toddlers? Arch Dis Child. 1992 Sep;67(9):1077–1079. doi: 10.1136/adc.67.9.1077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Pedersen S., Ostergaard P. A. Nasal inhalation as a cause of inefficient pulmonal aerosol inhalation technique in children. Allergy. 1983 Apr;38(3):191–194. doi: 10.1111/j.1398-9995.1983.tb01605.x. [DOI] [PubMed] [Google Scholar]
  6. Pedersen S., Steffensen G., Ekman I., Tönnesson M., Borgå O. Pharmacokinetics of budesonide in children with asthma. Eur J Clin Pharmacol. 1987;31(5):579–582. doi: 10.1007/BF00606634. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES